Cargando…

Community views on mass drug administration for filariasis: a qualitative evidence synthesis

BACKGROUND: The World Health Organization (WHO) recommends mass drug administration (MDA), giving a drug at regular intervals to a whole population, as part of the strategy for several disease control programmes in low‐ and middle‐income countries. MDA is currently WHO policy for areas endemic with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Taylor, Melissa, Thomas, Rebecca, Oliver, Sandy, Garner, Paul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Ltd 2022
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8851040/ https://www.ncbi.nlm.nih.gov/pubmed/35174482 http://dx.doi.org/10.1002/14651858.CD013638.pub2

Ejemplares similares

WILL MASS DRUG ADMINISTRATION ELIMINATE LYMPHATIC FILARIASIS? EVIDENCE FROM NORTHERN COASTAL TANZANIA
por: PARKER, MELISSA, et al.
Publicado: (2013)

COMMUNITY MEMBERS' PERCEPTIONS OF MASS DRUG ADMINISTRATION FOR CONTROL OF LYMPHATIC FILARIASIS IN RURAL AND URBAN TANZANIA
por: KISOKA, WILLIAM J., et al.
Publicado: (2016)

National Mass Drug Administration Costs for Lymphatic Filariasis Elimination
por: Goldman, Ann S., et al.
Publicado: (2007)

Elimination of lymphatic filariasis: current perspectives on mass drug administration
por: Gyapong, John O, et al.
Publicado: (2018)

Impact of mass drug administration for elimination of lymphatic filariasis in Nepal
por: Ojha, Chet Raj, et al.
Publicado: (2017)

Assessing factors influencing communities’ acceptability of mass drug administration for the elimination of lymphatic filariasis in Guyana
por: Niles, Reza A., et al.
Publicado: (2021)

Facilitators and barriers in implementation of mass drug administration for lymphatic filariasis elimination in India: A protocol for systematic review and qualitative meta-synthesis
por: Sinha, Abhinav, et al.
Publicado: (2022)

The fight against lymphatic filariasis: perceptions of community drug distributors during mass drug administration in coastal Kenya
por: Kusi, Caroline, et al.
Publicado: (2020)

Challenges in mass drug administration for treating lymphatic filariasis in Papua, Indonesia
por: Bhullar, Navneet, et al.
Publicado: (2010)

Factors determining noncompliance to mass drug administration for lymphatic filariasis elimination
por: Nujum, Zinia T, et al.
Publicado: (2012)

No evidence of lymphatic filariasis transmission in Bamako urban setting after three mass drug administration rounds
por: Coulibaly, Yaya Ibrahim, et al.
Publicado: (2022)

Perceived threat and benefit toward community compliance of filariasis’ mass drug administration in Pekalongan district, Indonesia
por: Widjanarko, Bagoes, et al.
Publicado: (2018)

Cessation of Mass Drug Administration for Lymphatic Filariasis in Zanzibar in 2006: Was Transmission Interrupted?
por: Rebollo, Maria P., et al.
Publicado: (2015)

Evaluation of mass drug administration in the program to control imported lymphatic filariasis in Thailand
por: Toothong, Tanaporn, et al.
Publicado: (2015)

The Health and Economic Burdens of Lymphatic Filariasis Prior to Mass Drug Administration Programs
por: Mathew, Christopher G, et al.
Publicado: (2020)

Factors Associated with the Acceptability of Mass Drug Administration for Filariasis: A Systematic Review
por: Abdul Halim, Ahmad Farid Nazmi, et al.
Publicado: (2022)

Population pharmacokinetic model of ivermectin in mass drug administration against lymphatic filariasis
por: Alshehri, Abdullah, et al.
Publicado: (2023)

Correction to: No evidence of lymphatic filariasis transmission in Bamako urban setting after three mass drug administration rounds
por: Coulibaly, Yaya Ibrahim, et al.
Publicado: (2022)

Data reporting constraints for the lymphatic filariasis mass drug administration activities in two districts in Ghana: A qualitative study
por: da-Costa Vroom, Frances Baaba, et al.
Publicado: (2015)

Reduction in Acute Filariasis Morbidity during a Mass Drug Administration Trial to Eliminate Lymphatic Filariasis in Papua New Guinea
por: Tisch, Daniel J., et al.
Publicado: (2011)

Community perspectives on persistent transmission of lymphatic filariasis in three hotspot districts in Ghana after 15 rounds of mass drug administration: a qualitative assessment
por: Ahorlu, Collins S. K., et al.
Publicado: (2018)

Lymphatic filariasis control in Tanzania: infection, disease perceptions and drug uptake patterns in an endemic community after multiple rounds of mass drug administration
por: Derua, Yahya A., et al.
Publicado: (2018)

Rapid molecular tests for tuberculosis and tuberculosis drug resistance: a qualitative evidence synthesis of recipient and provider views
por: Engel, Nora, et al.
Publicado: (2022)

Molecular Xenomonitoring Using Mosquitoes to Map Lymphatic Filariasis after Mass Drug Administration in American Samoa
por: Schmaedick, Mark A., et al.
Publicado: (2014)

Mass Drug Administration Coverage Evaluation Survey for Lymphatic Filariasis in Bagalkot and Gulbarga Districts
por: Patel, Prakash Kurubarahalli
Publicado: (2012)

Modeling the Impact and Costs of Semiannual Mass Drug Administration for Accelerated Elimination of Lymphatic Filariasis
por: Stolk, Wilma A., et al.
Publicado: (2013)

Are we nearly there yet? Coverage and compliance of mass drug administration for lymphatic filariasis elimination
por: Alexander, Neal D. E.
Publicado: (2015)

Factors Influencing Drug Uptake during Mass Drug Administration for Control of Lymphatic Filariasis in Rural and Urban Tanzania
por: Kisoka, William J., et al.
Publicado: (2014)

The safety of double- and triple-drug community mass drug administration for lymphatic filariasis: A multicenter, open-label, cluster-randomized study
por: Weil, Gary J., et al.
Publicado: (2019)

Transmission Assessment Surveys (TAS) to Define Endpoints for Lymphatic Filariasis Mass Drug Administration: A Multicenter Evaluation
por: Chu, Brian K., et al.
Publicado: (2013)

Lymphatic Filariasis Control in Tanzania: Effect of Repeated Mass Drug Administration with Ivermectin and Albendazole on Infection and Transmission
por: Simonsen, Paul E., et al.
Publicado: (2010)

Lymphatic filariasis control in Tanga Region, Tanzania: status after eight rounds of mass drug administration
por: Simonsen, Paul E, et al.
Publicado: (2014)

Albendazole alone or in combination with microfilaricidal drugs for lymphatic filariasis
por: Macfarlane, Cara L, et al.
Publicado: (2019)

An Evaluation of Mass Drug Administration Compliance Against Filariasis of Tikamgarh District of Madhya Pradesh-A Household-Based Community Study
por: Singh, Sandeep, et al.
Publicado: (2013)

How community engagement strategies shape participation in mass drug administration programmes for lymphatic filariasis: The case of Luangwa District, Zambia
por: Silumbwe, Adam, et al.
Publicado: (2019)

Coverage and compliance of mass drug administration in lymphatic filariasis amidst the COVID-19 pandemic: A community based epidemiological study
por: Chakraborty, Sumanta, et al.
Publicado: (2022)

Qualitative analysis of the impact of a lymphatic filariasis elimination programme using mass drug administration on Misima Island, Papua New Guinea
por: Wynd, Shona, et al.
Publicado: (2007)

Towards elimination of Lymphatic Filariasis in Kenya: improving advocacy, communication and social mobilization activities for mass drug administration, a qualitative study
por: Kibe, Lydiah W., et al.
Publicado: (2022)

Maintaining effective mass drug administration for lymphatic filariasis through in-process monitoring in Sierra Leone
por: Hodges, Mary H, et al.
Publicado: (2012)

A Review of Factors That Influence Individual Compliance with Mass Drug Administration for Elimination of Lymphatic Filariasis
por: Krentel, Alison, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_vrej61n4plieepvu6gvn22us8l